when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

LEADING · news · pharmadog

← back to LEADING

News mentioning LEADING

653 stories

Aug 6, 26Tarsus pays $450M for Alkeus and its phase 3-stage retinal disease drugfiercebiotech

Aug 6, 26Regulatory announcement no 19: Reporting of transactions made by persons discharging managerial responsibilities and their closely associated persons in InstallatørGruppen's sharesglobenewswire health

Aug 6, 26Regulatory announcement no 19: Reporting of transactions made by persons discharging managerial responsibilities and their closely associated persons in InstallatørGruppen's sharesglobenewswire health

Aug 6, 26Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated personsglobenewswire health

Aug 6, 26Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated personsglobenewswire health

Aug 6, 26Medline Industries, LP Issues Nationwide Recall of Hudson RCI Neonatal/Infant Heated Wire Breathing Circuitsfda medwatch

Aug 5, 26Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launchbiopharma dive

Aug 5, 26Bespoke gene-editing outfit abandons lead program, cuts ‘several’ employeesbiospace

Aug 5, 26Amgen’s MariTide stands alone after obesity cull while analysts seek more M&Abiospace

Aug 5, 26Fecal transplant increases tolerance to peanuts sixfold in small food allergy trialfiercebiotech

Aug 5, 26‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growthfiercebiotech

Aug 5, 26Lilly drops another gene therapy trial from $1B Prevail buyoutfiercebiotech

Aug 5, 26MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get themstat

Aug 5, 26Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist® Prefilled Syringe Due to Labeling Mix-upfda medwatch

Aug 4, 26Merck’s $10.8B Prometheus deal delivers another win—plus a Phase 2b missbiospace

Aug 4, 26J&J pharma leader to retire; Krystal slumps on gene therapy missbiopharma dive

Aug 4, 26Sanofi-backed Expedition uses $115M series B to advance COPD drug on phase 2 journeyfiercebiotech

Aug 4, 26Merck’s $11B anti-TL1A bet delivers 1 win, 1 loss in midphase inflammatory disease trialsfiercebiotech

Aug 3, 26Heart transplant candidates fail if they get too weak. New program tries inpatient prehabstat

Aug 3, 26After 5-month wait, BioNTech announces Sobi CEO will take on top job at mRNA companyfiercebiotech

Aug 2, 26STAT+: Michigan Supreme Court ruling allows probe into Lilly insulin pricingstat

Jul 31, 26Capricor CEO won’t rule out legal action against FDA after negative adcommbiospace

Jul 31, 26Lilly and Resilience invest $750M in diabetes and obesity drug device supplybiospace

Jul 31, 26‘It’s making a difference’: Madrigal CEO talks strategy behind MASH shopping spreefiercebiotech

Jul 31, 26Opinion: We once praised the American Diabetes Association’s courage. How things have changedstat

Jul 30, 26Alnylam plunges as earnings deliver ‘one-two punch’biopharma dive

Jul 30, 26Chutes & Ladders—Legend CEO departs without successor in placefiercebiotech

Jul 30, 26J&J secures right to take the helm in up to $925M Sail CAR T pactbiospace

Jul 30, 26Opinion: Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseasesstat

Jul 30, 26New funding, new jobs: 4 biotechs hiring after series B raisesbiospace

← prevpage 13 of 22next →